Frequency
Dupuytren contracture occurs in about 5 percent of people in the United States. The condition is 3 to 10 times more common in people of European descent than in those of non-European descent.
Causes
While the cause of Dupuytren contracture is unknown, changes in one or more genes are thought to affect the risk of developing this disorder. Some of the genes associated with the disorder are involved in a biological process called the Wnt signaling pathway. This pathway promotes the growth and division (proliferation) of cells and is involved in determining the specialized functions a cell will have (differentiation).
Abnormal proliferation and differentiation of connective tissue cells called fibroblasts are important in the development of Dupuytren contracture. The fascia of people with this disorder has an excess of myofibroblasts, which are a type of fibroblast containing protein strands called myofibrils. Myofibrils normally form the basic unit of muscle fibers, allowing them to contract. The increased number of myofibroblasts in this disorder cause abnormal contraction of the fascia and produce excess amounts of a connective tissue protein called type III collagen. The combination of abnormal contraction and excess type III collagen likely results in the changes in connective tissue that occurs in Dupuytren contracture. However, it is unknown how changes in genes that affect the Wnt signaling pathway are related to these abnormalities and how they contribute to the risk of developing this disorder.
Other risk factors for developing Dupuytren contracture may include smoking; extreme alcohol use; liver disease; diabetes; high cholesterol; thyroid problems; certain medications, such as those used to treat epilepsy (anticonvulsants); and previous injury to the hand.
Inheritance
Dupuytren contracture is usually passed down through generations in families and is the most common inherited disorder of connective tissue. The inheritance pattern is often unclear. Some people who inherit gene changes associated with Dupuytren contracture never develop the condition.
In some cases, Dupuytren contracture is not inherited and occurs in people with no history of the condition in their family. These sporadic cases tend to begin later and be less severe than familial cases.
Other Names for This Condition
- Contraction of palmar fascia
- Dupuytren disease
- Dupuytren's contracture
- Familial palmar fibromatosis
- Palmar fascial fibromatosis
- Palmar fibromas
Additional Information & Resources
Patient Support and Advocacy Resources
Clinical Trials
Catalog of Genes and Diseases from OMIM
Scientific Articles on PubMed
References
- Becker K, Tinschert S, Lienert A, Bleuler PE, Staub F, Meinel A, Rossler J, Wach W, Hoffmann R, Kuhnel F, Damert HG, Nick HE, Spicher R, Lenze W, Langer M, Nurnberg P, Hennies HC. The importance of genetic susceptibility in Dupuytren's disease. Clin Genet. 2015 May;87(5):483-7. doi: 10.1111/cge.12410. Epub 2014 May 15. Citation on PubMed
- Black EM, Blazar PE. Dupuytren disease: an evolving understanding of an age-old disease. J Am Acad Orthop Surg. 2011 Dec;19(12):746-57. doi: 10.5435/00124635-201112000-00005. Citation on PubMed
- Capstick R, Bragg T, Giele H, Furniss D. Sibling recurrence risk in Dupuytren's disease. J Hand Surg Eur Vol. 2013 May;38(4):424-9. doi: 10.1177/1753193412453359. Epub 2012 Jul 11. Citation on PubMed
- Debniak T, Zyluk A, Puchalski P, Serrano-Fernandez P. Common variants of the EPDR1 gene and the risk of Dupuytren's disease. Handchir Mikrochir Plast Chir. 2013 Oct;45(5):253-7. doi: 10.1055/s-0033-1357119. Epub 2013 Oct 2. Citation on PubMed
- Dolmans GH, Werker PM, Hennies HC, Furniss D, Festen EA, Franke L, Becker K, van der Vlies P, Wolffenbuttel BH, Tinschert S, Toliat MR, Nothnagel M, Franke A, Klopp N, Wichmann HE, Nurnberg P, Giele H, Ophoff RA, Wijmenga C; Dutch Dupuytren Study Group; German Dupuytren Study Group; LifeLines Cohort Study; BSSH-GODD Consortium. Wnt signaling and Dupuytren's disease. N Engl J Med. 2011 Jul 28;365(4):307-17. doi: 10.1056/NEJMoa1101029. Epub 2011 Jul 6. Citation on PubMed
- Larsen S, Krogsgaard DG, Aagaard Larsen L, Iachina M, Skytthe A, Frederiksen H. Genetic and environmental influences in Dupuytren's disease: a study of 30,330 Danish twin pairs. J Hand Surg Eur Vol. 2015 Feb;40(2):171-6. doi: 10.1177/1753193414535720. Epub 2014 May 16. Citation on PubMed or Free article on PubMed Central
- Mansur HG, Oliveira ER, Goncalves CB. Epidemiological analysis of patients with Dupuytren's disease. Rev Bras Ortop. 2017 Dec 14;53(1):10-14. doi: 10.1016/j.rboe.2017.12.003. eCollection 2018 Jan-Feb. Citation on PubMed or Free article on PubMed Central
- McFarlane RM. On the origin and spread of Dupuytren's disease. J Hand Surg Am. 2002 May;27(3):385-90. doi: 10.1053/jhsu.2002.32334. Citation on PubMed
- Michou L, Lermusiaux JL, Teyssedou JP, Bardin T, Beaudreuil J, Petit-Teixeira E. Genetics of Dupuytren's disease. Joint Bone Spine. 2012 Jan;79(1):7-12. doi: 10.1016/j.jbspin.2011.05.027. Epub 2011 Jul 30. Citation on PubMed
- Rodrigues JN, Becker GW, Ball C, Zhang W, Giele H, Hobby J, Pratt AL, Davis T. Surgery for Dupuytren's contracture of the fingers. Cochrane Database Syst Rev. 2015 Dec 9;2015(12):CD010143. doi: 10.1002/14651858.CD010143.pub2. Citation on PubMed or Free article on PubMed Central
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.